We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Biosimilars Market Taking Off, IQVIA Finds
The biosimilars market has had a plodding start in the U.S., but the products are finally picking up momentum, IQVIA reported, citing three examples of new products with strong potential.